Donmienne Leung
InvestorFounderDirector II, Head of AbbVie Ventures Europe at AbbVie · CEO at ThirtyFiveBio Limited
Oxford, England, United Kingdom
FoundedThirtyFiveBio Limited
About
Donmienne Leung leads a dedicated European venture mandate and, after 20+ years as a drug hunter and PhD medicinal chemist with active publications, provides hands-on scientific guidance to biotech boards.
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtech
CEO at ThirtyFiveBio Limited
Intro paths
In turn, Donmienne can intro founders to ThirtyFiveBio Limited's investors below.
ThirtyFiveBio Limited's investors · 1
Experience
- AbbVieDirector II, Head of Ventures Europecurrent2025 — presentOxford
- AbbVieDirector, AbbVie Ventures UK/Europe2023 — 2025Oxford, England, United Kingdom
- ThirtyFiveBioBoard Membercurrent2025 — present
- CephagenixBoard Membercurrent2025 — presentParis and Copenhagen
- EvolveImmune TherapeuticsBoard Membercurrent2024 — presentBranford, Connecticut, United States
- Endlyz TherapeuticsBoard Membercurrent2023 — presentOxford, England, United Kingdom
- Enthera PharmaceuticalsBoard Observer2023 — 2025Milan, Lombardy, Italy
- DISCO Pharmaceuticals GmbHBoard Observer2023 — 2025Cologne, North Rhine-Westphalia, Germany
- Absolute BiotechHead of Protein Engineering2021 — 2023Redcar
- Eli Lilly and CompanySenior Research Advisor2020 — 2021
- Eli Lilly and CompanyResearch Advisor2017 — 2020Greater San Diego Area
- Eli Lilly and CompanyPrinicipal Research Scientist2012 — 2017
- Eli Lilly and CompanySenior Research Scientist2008 — 2012
- Eli Lilly and CompanyResearch Scientist2005 — 2008
- The Scripps Research InstitutePostdoctoral Scientist2001 — 2005San Diego, California, United States
- University of QueenslandPHD Student1997 — 2001Brisbane, Australia
- University of MelbourneHonors Student1996 — 1997Melbourne, Victoria, Australia
- Walter and Eliza Hall Institute of Medical ResearchResearch Assistant1994 — 1996Melbourne, Victoria, Australia
Education
- The University of QueenslandDoctor, Philosophy1997 — 2000
- University of MelbourneBachelor of Science (Honours), Chemistry / Biochemistry1996
- University of MelbourneBachelor of Science & Bachelor of Engineering, Biochemistry1992 — 1995
Skills & more
+12 more
HPLCDrug DevelopmentMedicinal ChemistryCell BiologyCell CultureBiotechnologyImmunologyELISAChromatographyWestern BlottingVolunteeringDrug DesignLanguages Chinese · English
- VC University — VC University
From Donmienne's professional profile.
Colleagues at AbbVie
Frequently asked questions
- Where does Donmienne Leung work?
- Donmienne Leung is Director II, Head of AbbVie Ventures Europe at AbbVie and CEO at ThirtyFiveBio Limited.
- What does Donmienne Leung invest in?
- Donmienne Leung invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech.
- What companies did Donmienne Leung found?
- Donmienne Leung founded ThirtyFiveBio Limited.
Founder mafias
The University of Queensland mafia24
Also came through, then founded or led a company.
+ 17 more
University of Melbourne mafia21
Also came through, then founded or led a company.
+ 14 more
AbbVie mafia7
Also came through, then founded or led a company.
Enthera mafia2
Also came through, then founded or led a company.
Same school
Also attended The University of Queensland114
+ 108 more
Also attended University of Melbourne206
+ 200 more
Shared employers
Also worked at AbbVie40
+ 34 more
Also worked at Enthera Pharmaceuticals5
Also worked at DISCO Pharmaceuticals GmbH3
Also worked at Eli Lilly and Company79
+ 73 more

































:format(webp)/f/174198/3860x2650/d857c55b6f/steel-blue-clarissa.png)












